| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 1241 | 3-N-Boc-5′-O-dimethoxytrityl-3′-O-nosyl-thymidine (GMP) |
1241.0025: 25 mg per vial 1241.0040: 40 mg per vial Please inquire for customized filling and bulk quantities.
|
|
Precursor for [18F]FLT
(3′-Deoxy-3′-[18F]fluorothymidine) |
||
| Manufactured according to GMP requirements for APIs for use in clinical trials (ICH Q7 chapter 19) | ||
| Molar Mass: 829.87 | ||
| C42H43N3O13S | ||
| [444717-23-1] | ||
| Yellowish solid packaged in clear glass vials. (10 ml headspace) | ||
| Purity: ≥ 97 % | ||
|
Certificates:
CoA with NMR and IR spectra (identity); HPLC (purity); GC (residual solvents); Content Silver (AAS); microbiology test |
||
|
Chemical Name: CA index name: 1(2H)-Pyrimidinecarboxylic acid, 3-[2-deoxy-3-O-[(4-nitrophenyl)sulfonyl]-5-O-(triphenylmethyl)-β-D-threo-pentofuranosyl]-3,6-dihydro-5-methyl-2,6-dioxo-, 1,1-dimethylethyl ester |
||
|
Synonymes: 3-N-Boc-5′-O-dimethoxytrityl-3′-O-nosyl-thymidine; 3-N-Boc-1-[5-O-(4,4′-dimethoxytrityl)-3-O-nitrophenylsulfonyl-2-deoxy-β-D-lyxofuranosyl]thymidine; 1-(2′-Deoxy-3′-O-(4-nitrobenzenesulfonyl)-5′-O-(4,4′-dimethoxytrityl)-β-D-threo-pentafuranosyl)-3-(tert-butyloxycarbonyl)thymine; Boc-FLT-Precursor; Boc-FLT |
||
|
Literature: Same as product number 1240. |
||
| date of product catalogue issue: 10 May 2017 | ||